Literature DB >> 26722180

Utility of indium-111 octreotide to identify a cardiac metastasis of a carcinoid neoplasm.

Mohammed Farooqui1, Sulaiman Rathore1, Timothy Ball1.   

Abstract

Carcinoid heart disease is classically described as right-sided valvular pathology. Solid cardiac metastases from carcinoid tumors are seldom reported. A multimodality imaging approach is needed to diagnose and localize this disease. Biopsy remains the gold standard to confirm the diagnosis of carcinoid. Octreotide uptake is characteristic of carcinoid tumor but not myxoma; thus, an indium-111 octreotide scan is very specific for the diagnosis of carcinoid tumor and helps in assessing the extent of carcinoid disease. We present a case in which an indium-111 octreotide scan revealed uptake in three distinct masses in the colon, liver, and right ventricle. The results of the scan were contradictory to the biopsy results, which were diagnostic for hepatic carcinoid and cardiac myxoma.

Entities:  

Year:  2016        PMID: 26722180      PMCID: PMC4677865          DOI: 10.1080/08998280.2016.11929369

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN: 0899-8280


  10 in total

1.  In-111 octreotide scan in a case of a neuroendocrine tumor of unknown origin.

Authors:  D Fuster; M Navasa; F Pons; S Vidal-Sicart; J J Mateos; F Lomeña; J Rodes; R Herranz
Journal:  Clin Nucl Med       Date:  1999-12       Impact factor: 7.794

Review 2.  The clinical presentation and management of carcinoid heart disease.

Authors:  R Dobson; M I Burgess; D M Pritchard; D J Cuthbertson
Journal:  Int J Cardiol       Date:  2014-02-28       Impact factor: 4.164

3.  Specificity of somatostatin receptor scintigraphy: a prospective study and effects of false-positive localizations on management in patients with gastrinomas.

Authors:  F Gibril; J C Reynolds; C C Chen; F Yu; S U Goebel; J Serrano; J L Doppman; R T Jensen
Journal:  J Nucl Med       Date:  1999-04       Impact factor: 10.057

4.  [111In-DTPA-D-Phe1]octreotide scintigraphy in patients with carcinoid tumours: the predictive value for somatostatin analogue treatment.

Authors:  E T Janson; J E Westlin; B Eriksson; H Ahlström; S Nilsson; K Oberg
Journal:  Eur J Endocrinol       Date:  1994-12       Impact factor: 6.664

5.  Metastatic carcinoid tumor to the heart: echocardiographic-pathologic study of 11 patients.

Authors:  Utpal H Pandya; Patricia A Pellikka; Maurice Enriquez-Sarano; William D Edwards; Hartzell V Schaff; Heidi M Connolly
Journal:  J Am Coll Cardiol       Date:  2002-10-02       Impact factor: 24.094

6.  Differential diagnosis of intracavitary tumors obstructing the right ventricular outflow tract.

Authors:  A S Gopal; J A Stathopoulos; N Arora; S Banerjee; F Messineo
Journal:  J Am Soc Echocardiogr       Date:  2001-09       Impact factor: 5.251

7.  An analysis of 8305 cases of carcinoid tumors.

Authors:  I M Modlin; A Sandor
Journal:  Cancer       Date:  1997-02-15       Impact factor: 6.860

Review 8.  Somatostatin receptor imaging.

Authors:  Dik J Kwekkeboom; Eric P Krenning
Journal:  Semin Nucl Med       Date:  2002-04       Impact factor: 4.446

Review 9.  Octreotide scanning for carcinoid tumours.

Authors:  M Critchley
Journal:  Postgrad Med J       Date:  1997-07       Impact factor: 2.401

Review 10.  Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients.

Authors:  E P Krenning; D J Kwekkeboom; W H Bakker; W A Breeman; P P Kooij; H Y Oei; M van Hagen; P T Postema; M de Jong; J C Reubi
Journal:  Eur J Nucl Med       Date:  1993-08
  10 in total
  3 in total

Review 1.  Carcinoid Heart Disease: Review of Current Knowledge.

Authors:  Pradhum Ram; Jorge L Penalver; Kevin Bryan U Lo; Janani Rangaswami; Gregg S Pressman
Journal:  Tex Heart Inst J       Date:  2019-02-01

2.  Cardiac metastasis of neuroendocrine tumor of the thymus diagnosed by cardiac magnetic resonance T1 mapping: a case report.

Authors:  Jiamin Zhang; Mu Zeng
Journal:  J Int Med Res       Date:  2020-06       Impact factor: 1.671

3.  A concealed carcinoid cardiac metastasis uncovered by comprehensive cardiovascular magnetic resonance-based tissue characterization: a case report.

Authors:  Georgios Georgiopoulos; Panagiota Mitropoulou; Pier Giorgio Masci; Juerg Schwitter
Journal:  Eur Heart J Case Rep       Date:  2020-11-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.